ASLTY (Asymchem Laboratories Tianjin Co) 1-Year Sharpe Ratio: 1.30 (As of Jul. 04, 2026)


ASLTY Asymchem Laboratories Tianjin Co Ltd ASLTY
69 GF Score
Price $6.37
GF Value $3.88
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Asymchem Laboratories Tianjin Co 1-Year Sharpe Ratio?

Asymchem Laboratories Tianjin Co ASLTY 69 1-Year Sharpe Ratio is 1.30 as of Jul. 04, 2026. GuruFocus rates ASLTY with a GF Score™ of 69/100 and a GF Value™ of $3.88 (Significantly Overvalued). The stock has 9 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-04), Asymchem Laboratories Tianjin Co's 1-Year Sharpe Ratio is 1.30.

Asymchem Laboratories Tianjin Co  (OTCPK:ASLTY) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Asymchem Laboratories Tianjin Co 1-Year Sharpe Ratio Related Terms

ASLTY vs VRTX, REGN, ALNY: 1-Year Sharpe Ratio Comparison

For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Asymchem Laboratories Tianjin Co 1-Year Sharpe Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Asymchem Laboratories Tianjin Co's 1-Year Sharpe Ratio falls into.


ASLTY
69GF Score
Asymchem Laboratories Tianjin Co Ltd ASLTY
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asymchem Laboratories Tianjin Co 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 1.30 mean?
Asymchem Laboratories Tianjin Co (ASLTY) has a 1-Year Sharpe Ratio of 1.30 as of Jul. 04, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Asymchem Laboratories Tianjin Co and its competitors.
Is Asymchem Laboratories Tianjin Co's 1-Year Sharpe Ratio too high?
Asymchem Laboratories Tianjin Co's current 1-Year Sharpe Ratio is 1.30. Overall, Asymchem Laboratories Tianjin Co has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asymchem Laboratories Tianjin Co's 1-Year Sharpe Ratio compare to VRTX and REGN?
Asymchem Laboratories Tianjin Co's 1-Year Sharpe Ratio of 1.30 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Biotechnology company?
A good 1-Year Sharpe Ratio depends on the Biotechnology industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Asymchem Laboratories Tianjin Co and its competitors. Asymchem Laboratories Tianjin Co's current 1-Year Sharpe Ratio is 1.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asymchem Laboratories Tianjin Co stock overvalued right now?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co (ASLTY) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.88, compared to a current price of $6.37 — trading 64.2% above its estimated fair value. The current 1-Year Sharpe Ratio is 1.30. Asymchem Laboratories Tianjin Co's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Asymchem Laboratories Tianjin Co (ASLTY), the current 1-Year Sharpe Ratio is 1.30 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Asymchem Laboratories Tianjin Co (ASLTY) Overvalued in 2026?

Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co stock appears to be overvalued. The current stock price of $6.37 is trading 64.2% above its estimated GF Value™ of $3.88. GuruFocus considers Asymchem Laboratories Tianjin Co to be Significantly Overvalued.

Key valuation signals for ASLTY:

  • 1-Year Sharpe Ratio: 1.30
  • GF Value™: $3.88 vs. price of $6.37 (64.2% above fair value)
  • GF Score™: 69/100 with 9 warning signs

No single metric tells the full story. See the ASLTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Asymchem Laboratories Tianjin Co Business Description

Other Exchanges 06821:Hong Kong002821:China
Address No. 6 Dongting 3rd Street, Economic and Technological Development Zone, Tianjin, CHN, 300457
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
69GF Score

Get the complete analysis for ASLTY

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.37
Price
$3.88
GF Value